BioNTech will do without $100M from Hong Kong-based series B investor

An updated IPO prospectus revealed that BioNTech no longer expects a $100 million contribution to its previously announced series B round from an undisclosed Hong Kong-based investor.

The company's initial IPO filing on Sept. 10 had said BioNTech SE was still waiting on the money and that the investor was still committed to the deal, despite "ongoing geopolitical disruptions in Hong Kong and the ongoing trade dispute between the U.S. and China" that were delaying the investment's completion (see "Trade War, Hong Kong Unrest May Be Delaying $100M to BioNTech")...